 Clinical Study
December 22, 2024
Exploring the Journey of APX3330 in Diabetic Retinopathy: A New Horizon in Ophthalmic Treatment Diabetic retinopathy is a prevalent microvascular complication of diabetes, often leading to vision impairment or loss. Treatment options have remained limited, necessitating continuous exploration into novel therapies....
|
Clinical Study
December 22, 2024
QRX003: A Promising New Approach in the Management of Netherton Syndrome Quoin Pharmaceuticals Ltd. a company distinguished by its commitment to addressing unmet medical needs in rare and orphan diseases, recently received FDA clearance to commence a new clinical trial to evaluate QRX003, a topical lotion designed f...
|
Product Service News
December 22, 2024
Silynxcom: Pioneering Advancements in Tactical Communication and Drone Detection As global military and law enforcement agencies strive for cutting-edge technology to enhance operational safety and efficiency, Silynxcom Ltd. (NYSE American: SYNX) is establishing itself as a formidable leader in the field of ruggediz...
|
|
 Merger and Acquisition
December 22, 2024
NBT Bancorp Inc. Receives Regulatory Approval: A Game-Changer in the Banking LandscapeIn a landmark development for the banking sector, NBT Bancorp Inc. has been granted regulatory approval for its proposed merger with Evans Bancorp, Inc. This pivotal move is set to reshape the competitive landscape and enhance oper...
 Merger and Acquisition
December 22, 2024
Battalion Oil Corporation s Strategic Shift: Termination of Merger with Fury Resources Raises Questions on Market PositionIn a significant turn of events, Battalion Oil Corporation (NYSE American: BATL) has announced the termination of its previously disclosed Agreement and Plan of Merger with Fury Resources, Inc. ...
|
|
Our most Popular Articles
|
Business Update
October 12, 2024
D.A. Davidson Facilitates Strategic Acquisition of APSCO by Ingersoll Rand: A Milestone in Hydraulic and Pneumatic SolutionsIn a significant development within the industrial sector, D.A. Davidson has announced its role as the exclusive financial advisor to Air Power Systems Co. (APSCO) in its recent acquisition by...
|
Business Update
September 27, 2024
In an era marked by complex supply chain dynamics and rapidly shifting consumer demands, businesses are increasingly turning to innovative technology solutions to enhance their operational efficiency. A recent collaboration between Teleflex Incorporated, a global leader in medical technologies, and o9 Solutions, an ...
|
Product Service News
October 6, 2024
In a significant stride forward in the field of musculoskeletal health, Globus Medical, Inc. (NYSE: GMED), a leading innovator in orthopedic solutions, has announced the expansion of its already comprehensive orthopedic trauma product lineup. The latest announcement, dated October 2, 2024, signals a pivotal growth p...
|
|
|
Company News
|
Clinical Study
December 22, 2024
QRX003: A Promising New Approach in the Management of Netherton Syndrome Quoin Pharmaceuticals Ltd. a company distinguished by its commitment to addressing unmet medical needs in rare and orphan diseases, recently received FDA clearance to commence a new clinical trial to evaluate QRX003, a topical lotion designed f...
|
Product Service News
December 22, 2024
Silynxcom: Pioneering Advancements in Tactical Communication and Drone Detection As global military and law enforcement agencies strive for cutting-edge technology to enhance operational safety and efficiency, Silynxcom Ltd. (NYSE American: SYNX) is establishing itself as a formidable leader in the field of ruggediz...
|
Clinical Study
December 22, 2024
Advancing Cancer Treatment: Promising Data from Xilio TherapeuticsIn the rapidly evolving field of biotechnology, Xilio Therapeutics Inc. (NASDAQ: XLO) is making significant strides with its innovative approaches to cancer treatment. The company recently announced exciting developments regarding two important clini...
|
|
|
Company News
 Partnership
December 22, 2024
|
Company News
 Product Service News
December 22, 2024
|
Company News
 Contract
December 22, 2024
|
More Company News
|
Clinical Study
December 22, 2024
|
Clinical Study
December 22, 2024
|
Clinical Study
December 22, 2024
|
Product Service News
December 22, 2024
|
Announcement
December 22, 2024
|
Clinical Study
December 22, 2024
|
Product Service News
December 22, 2024
|
Business Update
December 22, 2024
|
Business Update
December 22, 2024
|
Business Update
December 22, 2024
|
|
|
|
Related News
|
Business Update
|
Business Update
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Merger and Acquisition
NBT Bancorp Inc. Receives Regulatory Approval: A Game-Changer in the Banking LandscapeIn a landmark development for the banking sector, NBT Bancorp Inc. has been granted regulatory approval for its proposed merger with Evans Bancorp, Inc. This pivotal move is set to reshape the competitive landscape and enhance oper...
|
|
Merger and Acquisition
Battalion Oil Corporation s Strategic Shift: Termination of Merger with Fury Resources Raises Questions on Market PositionIn a significant turn of events, Battalion Oil Corporation (NYSE American: BATL) has announced the termination of its previously disclosed Agreement and Plan of Merger with Fury Resources, Inc. ...
|
 Merger and Acquisition
Breaking News: Banzai to Expand Portfolio with Vidello: Next-Generation Video Creation, Editing, and Marketing SuiteBanzai International Inc. (NASDAQ: BNZI), a growing contender in the Software & Programming sector, has announced an exciting new acquisition that signals a major leap in its digital capabilities. On D...
|
 Clinical Study
The therapeutic landscape for central nervous system (CNS) disorders is evolving, with advancements in targeted biologics leading to new avenues for treatment. A recent announcement by Alumis regarding the positive results from a Phase 1 trial of the oral TYK2 inhibitor A-005 highlights a significant step forward i...
|
 Clinical Study
Exploring the Journey of APX3330 in Diabetic Retinopathy: A New Horizon in Ophthalmic Treatment Diabetic retinopathy is a prevalent microvascular complication of diabetes, often leading to vision impairment or loss. Treatment options have remained limited, necessitating continuous exploration into novel therapies....
|
Our Most Popular Articles
|
 Business Update
D.A. Davidson Facilitates Strategic Acquisition of APSCO by Ingersoll Rand: A Milestone in Hydraulic and Pneumatic SolutionsIn a significant development within the industrial sector, D.A. Davidson has announced its role as the exclusive financial advisor to Air Power Systems Co. (APSCO) in its recent acquisition by...
|
 Business Update
In an era marked by complex supply chain dynamics and rapidly shifting consumer demands, businesses are increasingly turning to innovative technology solutions to enhance their operational efficiency. A recent collaboration between Teleflex Incorporated, a global leader in medical technologies, and o9 Solutions, an ...
|
 Product Service News
In a significant stride forward in the field of musculoskeletal health, Globus Medical, Inc. (NYSE: GMED), a leading innovator in orthopedic solutions, has announced the expansion of its already comprehensive orthopedic trauma product lineup. The latest announcement, dated October 2, 2024, signals a pivotal growth p...
|
More News
|
 Clinical Study
QRX003: A Promising New Approach in the Management of Netherton Syndrome Quoin Pharmaceuticals Ltd. a company distinguished by its commitment to addressing unmet medical needs in rare and orphan diseases, recently received FDA clearance to commence a new clinical trial to evaluate QRX003, a topical lotion designed f...
|
 Product Service News
Silynxcom: Pioneering Advancements in Tactical Communication and Drone Detection As global military and law enforcement agencies strive for cutting-edge technology to enhance operational safety and efficiency, Silynxcom Ltd. (NYSE American: SYNX) is establishing itself as a formidable leader in the field of ruggediz...
|
 Clinical Study
Advancing Cancer Treatment: Promising Data from Xilio TherapeuticsIn the rapidly evolving field of biotechnology, Xilio Therapeutics Inc. (NASDAQ: XLO) is making significant strides with its innovative approaches to cancer treatment. The company recently announced exciting developments regarding two important clini...
|
 Partnership
In a landmark announcement that underscores the burgeoning intersection of technology and sustainability within the transportation sector, Dragonfly Energy Holdings Corp, a preeminent player in energy storage and battery technology, has entered into a strategic partnership with Stevens Transport, Inc. This collabora...
|
 Product Service News
The article discusses the noteworthy contributions of Clearside Biomedical in the field of retinal drug development, as presented by Dr. Victor Chong at the Edridge Green Lecture. The subsequent publication of these insights in the peer-reviewed journal Eye underscores the significance of innovation and regulator...
|
 Contract
Lifecore Biomedical and Nirsum Labs Collaborate on Development of Innovative Opioid Use Disorder Treatment Lifecore Biomedical, a renowned contract development and manufacturing organization (CDMO), has recently been selected by Nirsum Labs to provide comprehensive development and manufacturing services for NRS-033,...
|
 Clinical Study
Regeneron Pharmaceuticals, a renowned science-driven biotechnology company, continues to forge new grounds in therapeutic development with its recent announcements surrounding its investigational antibodies and ongoing advancements with the drug Dupixent (dupilumab). Exciting Progress in Thrombosis ManagementRegener...
|
 Clinical Study
Bio-Path Holdings Advances BP1001-A: A New Prospect for Treating Obesity in Type 2 Diabetes Patients Bio-Path Holdings Inc has announced the commencement of preclinical testing for its new therapeutic candidate, BP1001-A, which may offer a promising solution in enhancing insulin sensitivity for individuals suffering...
|
|
Clinical Study
In an exciting development for patients battling relapsed or refractory Waldenstrom’s macroglobulinemia, Nurix Therapeutics Inc. has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its promising investigational drug, NX-5948. This significant acknowledgment follows the presenta...
|
 Product Service News
NewGen s Strategic foray into Digital Assets: A Calculated Leap into the Future In an era where digital economic dynamics are rapidly evolving, NewGen has made a decisive move to stake its claim in the burgeoning realm of digital assets. Engaging the expertise of OSL, a leading platform in virtual asset services, Ne...
|
 Announcement
In a significant move within the telecommunications sector, VEON Ltd. the global digital operator, has officially relocated its headquarters from Amsterdam to Dubai, United Arab Emirates. This transition, announced on 19 December 2024, marks a pivotal moment in VEON’s journey towards enhancing its international pr...
|
|
Clinical Study
Data and Safety Monitoring Board Endorses Continued Investigation of OCU410 in Phase 2 ArMaDa Clinical Trial MALVERN, Pa. Dec. 19, 2024 Ocugen, Inc. (NASDAQ: OCGN), a pioneering biotechnology firm known for its focus on novel gene and cell therapies, biologics, and vaccines, has announced a significant development i...
|
 Product Service News
In an era marked by escalating cyber threats, Radware is making significant strides in fortifying application and network securities for some of the industry’s most prominent entities. Recently, the company expanded its AI-driven protection services for a top five bank in Italy amid a surge in web DDoS (Distributed Denial-of-Service) attacks and the impending compliance deadline set by the Digital Operational Resilience Act (DORA). This proactive approach underscores the critical need for financial institutions to not only defend against evolving cyber threats but also align with regulatory expectations.Web DDoS attacks have surged, presenting a formidable challenge for large organizations that require robust, scalable security measures. Banks, in particular, are prime targets due to the sensitive nature of their operations and the vast sums of money at stake. Radware s new AI-driven solutions aim to address these vulnerabilities, ensuring that financial institutions can sustain operational continuity even in the face of sophisticated cyber incursions.
|
 Business Update
Strategic Moves and Commitments: WM Technology s Latest Developments in the Cannabis IndustryIn a momentous set of developments, WM Technology, Inc. (Nasdaq: MAPS), a key player in providing technological and software solutions to the cannabis industry, has confirmed the receipt of a non-binding proposal from its c...
|
 Business Update
In a strategic move to bolster its offerings, Prudential Financial, Inc. (NYSE: PRU) has announced a collaboration with Empathy, a bereavement support platform, to provide enhanced workplace benefits that cater to employees and their families coping with the loss of a loved one. This partnership comes in response to...
|
 Business Update
More Vegas, More Experiences: Hyatt s Vision for the Future In a bold move to solidify its presence on the Las Vegas Strip, Hyatt Hotels Corporation has announced a long-term licensing agreement with The Venetian Resort Las Vegas. In doing so, Hyatt aims to enhance its portfolio of luxury accommodations by making t...
|
|
|
|
|
